Relugolix–estradiol–norethisterone acetate for treating moderate to severe symptoms of uterine fibroids. NICE technology appraisal guidance 832
National Institute for Health and Care Excellence (NICE)
Record ID 32018011873
English
Details
Project Status:
Completed
URL for project:
https://www.nice.org.uk/guidance/ta832
Year Published:
2022
URL for published report:
https://www.nice.org.uk/guidance/ta832
English language abstract:
An English language summary is available
Publication Type:
Full HTA
Country:
England
MeSH Terms
- Leiomyoma
- Estradiol
- Androgen Antagonists
- Drug Therapy, Combination
- Norethindrone Acetate
- Uterine Neoplasms
Contact
Organisation Name:
National Institute for Health and Care Excellence
Contact Address:
Level 1A, City Tower, Piccadilly Plaza, Manchester, M1 4BT
Contact Name:
nice@nice.nhs.uk
Contact Email:
nice@nice.nhs.uk
Copyright:
National Institute for Health and Care Excellence (NICE)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.